Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > LAMA2(Gene name) > Human
  • Add your favorite
  • LAMA2 (Gene name),
  • Laminin subunit alpha-2 (Protein name ),  LAMA2_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    LAMA2(LAMM);
    Protein name:
    Laminin subunit alpha-2;
    Alternative:
    Laminin-12 subunit alpha;Laminin M chain;Laminin-4 subunit alpha;Laminin-2 subunit alpha;Merosin heavy chain;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Laminin is a complex glycoprotein, consisting of three different polypeptide chains (alpha, beta, gamma), which are bound to each other by disulfide bonds into a cross-shaped molecule comprising one long and three short arms with globules at each end. Alpha-2 is a subunit of laminin-2 (laminin-211 or merosin), laminin-4 (laminin-221 or S-merosin) and laminin-12 (laminin-213). Interacts with FBLN1, FBLN2 and NID2.
    Function:
    Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.
    Subcellular Location:
    Secreted extracellular space extracellular matrix basement membrane Major component.
    Protein Attributes:
    Sequence length:
    3122
    Sequence:
    50:
    MPGAAGVLLL | LLLSGGLGGV | QAQRPQQQRQ | SQAHQQRGLF | PAVLNLASNA | 
    100:
    LITTNATCGE | KGPEMYCKLV | EHVPGQPVRN | PQCRICNQNS | SNPNQRHPIT | 
    150:
    NAIDGKNTWW | QSPSIKNGIE | YHYVTITLDL | QQVFQIAYVI | VKAANSPRPG | 
    200:
    NWILERSLDD | VEYKPWQYHA | VTDTECLTLY | NIYPRTGPPS | YAKDDEVICT | 
    250:
    SFYSKIHPLE | NGEIHISLIN | GRPSADDPSP | ELLEFTSARY | IRLRFQRIRT | 
    300:
    LNADLMMFAH | KDPREIDPIV | TRRYYYSVKD | ISVGGMCICY | GHARACPLDP | 
    350:
    ATNKSRCECE | HNTCGDSCDQ | CCPGFHQKPW | RAGTFLTKTE | CEACNCHGKA | 
    400:
    EECYYDENVA | RRNLSLNIRG | KYIGGGVCIN | CTQNTAGINC | ETCTDGFFRP | 
    450:
    KGVSPNYPRP | CQPCHCDPIG | SLNEVCVKDE | KHARRGLAPG | SCHCKTGFGG | 
    500:
    VSCDRCARGY | TGYPDCKACN | CSGLGSKNED | PCFGPCICKE | NVEGGDCSRC | 
    550:
    KSGFFNLQED | NWKGCDECFC | SGVSNRCQSS | YWTYGKIQDM | SGWYLTDLPG | 
    600:
    RIRVAPQQDD | LDSPQQISIS | NAEARQALPH | SYYWSAPAPY | LGNKLPAVGG | 
    650:
    QLTFTISYDL | EEEEEDTERV | LQLMIILEGN | DLSISTAQDE | VYLHPSEEHT | 
    700:
    NVLLLKEESF | TIHGTHFPVR | RKEFMTVLAN | LKRVLLQITY | SFGMDAIFRL | 
    750:
    SSVNLESAVS | YPTDGSIAAA | VEVCQCPPGY | TGSSCESCWP | RHRRVNGTIF | 
    800:
    GGICEPCQCF | GHAESCDDVT | GECLNCKDHT | GGPYCDKCLP | GFYGEPTKGT | 
    850:
    SEDCQPCACP | LNIPSNNFSP | TCHLDRSLGL | ICDGCPVGYT | GPRCERCAEG | 
    900:
    YFGQPSVPGG | SCQPCQCNDN | LDFSIPGSCD | SLSGSCLICK | PGTTGRYCEL | 
    950:
    CADGYFGDAV | DAKNCQPCRC | NAGGSFSEVC | HSQTGQCECR | ANVQGQRCDK | 
    1000:
    CKAGTFGLQS | ARGCVPCNCN | SFGSKSFDCE | ESGQCWCQPG | VTGKKCDRCA | 
    1050:
    HGYFNFQEGG | CTACECSHLG | NNCDPKTGRC | ICPPNTIGEK | CSKCAPNTWG | 
    1100:
    HSITTGCKAC | NCSTVGSLDF | QCNVNTGQCN | CHPKFSGAKC | TECSRGHWNY | 
    1150:
    PRCNLCDCFL | PGTDATTCDS | ETKKCSCSDQ | TGQCTCKVNV | EGIHCDRCRP | 
    1200:
    GKFGLDAKNP | LGCSSCYCFG | TTTQCSEAKG | LIRTWVTLKA | EQTILPLVDE | 
    1250:
    ALQHTTTKGI | VFQHPEIVAH | MDLMREDLHL | EPFYWKLPEQ | FEGKKLMAYG | 
    1300:
    GKLKYAIYFE | AREETGFSTY | NPQVIIRGGT | PTHARIIVRH | MAAPLIGQLT | 
    1350:
    RHEIEMTEKE | WKYYGDDPRV | HRTVTREDFL | DILYDIHYIL | IKATYGNFMR | 
    1400:
    QSRISEISME | VAEQGRGTTM | TPPADLIEKC | DCPLGYSGLS | CEACLPGFYR | 
    1450:
    LRSQPGGRTP | GPTLGTCVPC | QCNGHSSLCD | PETSICQNCQ | HHTAGDFCER | 
    1500:
    CALGYYGIVK | GLPNDCQQCA | CPLISSSNNF | SPSCVAEGLD | DYRCTACPRG | 
    1550:
    YEGQYCERCA | PGYTGSPGNP | GGSCQECECD | PYGSLPVPCD | PVTGFCTCRP | 
    1600:
    GATGRKCDGC | KHWHAREGWE | CVFCGDECTG | LLLGDLARLE | QMVMSINLTG | 
    1650:
    PLPAPYKMLY | GLENMTQELK | HLLSPQRAPE | RLIQLAEGNL | NTLVTEMNEL | 
    1700:
    LTRATKVTAD | GEQTGQDAER | TNTRAKSLGE | FIKELARDAE | AVNEKAIKLN | 
    1750:
    ETLGTRDEAF | ERNLEGLQKE | IDQMIKELRR | KNLETQKEIA | EDELVAAEAL | 
    1800:
    LKKVKKLFGE | SRGENEEMEK | DLREKLADYK | NKVDDAWDLL | REATDKIREA | 
    1850:
    NRLFAVNQKN | MTALEKKKEA | VESGKRQIEN | TLKEGNDILD | EANRLADEIN | 
    1900:
    SIIDYVEDIQ | TKLPPMSEEL | NDKIDDLSQE | IKDRKLAEKV | SQAESHAAQL | 
    1950:
    NDSSAVLDGI | LDEAKNISFN | ATAAFKAYSN | IKDYIDEAEK | VAKEAKDLAH | 
    2000:
    EATKLATGPR | GLLKEDAKGC | LQKSFRILNE | AKKLANDVKE | NEDHLNGLKT | 
    2050:
    RIENADARNG | DLLRTLNDTL | GKLSAIPNDT | AAKLQAVKDK | ARQANDTAKD | 
    2100:
    VLAQITELHQ | NLDGLKKNYN | KLADSVAKTN | AVVKDPSKNK | IIADADATVK | 
    2150:
    NLEQEADRLI | DKLKPIKELE | DNLKKNISEI | KELINQARKQ | ANSIKVSVSS | 
    2200:
    GGDCIRTYKP | EIKKGSYNNI | VVNVKTAVAD | NLLFYLGSAK | FIDFLAIEMR | 
    2250:
    KGKVSFLWDV | GSGVGRVEYP | DLTIDDSYWY | RIVASRTGRN | GTISVRALDG | 
    2300:
    PKASIVPSTH | HSTSPPGYTI | LDVDANAMLF | VGGLTGKLKK | ADAVRVITFT | 
    2350:
    GCMGETYFDN | KPIGLWNFRE | KEGDCKGCTV | SPQVEDSEGT | IQFDGEGYAL | 
    2400:
    VSRPIRWYPN | ISTVMFKFRT | FSSSALLMYL | ATRDLRDFMS | VELTDGHIKV | 
    2450:
    SYDLGSGMAS | VVSNQNHNDG | KWKSFTLSRI | QKQANISIVD | IDTNQEENIA | 
    2500:
    TSSSGNNFGL | DLKADDKIYF | GGLPTLRNLS | MKARPEVNLK | KYSGCLKDIE | 
    2550:
    ISRTPYNILS | SPDYVGVTKG | CSLENVYTVS | FPKPGFVELS | PVPIDVGTEI | 
    2600:
    NLSFSTKNES | GIILLGSGGT | PAPPRRKRRQ | TGQAYYAILL | NRGRLEVHLS | 
    2650:
    TGARTMRKIV | IRPEPNLFHD | GREHSVHVER | TRGIFTVQVD | ENRRYMQNLT | 
    2700:
    VEQPIEVKKL | FVGGAPPEFQ | PSPLRNIPPF | EGCIWNLVIN | SVPMDFARPV | 
    2750:
    SFKNADIGRC | AHQKLREDED | GAAPAEIVIQ | PEPVPTPAFP | TPTPVLTHGP | 
    2800:
    CAAESEPALL | IGSKQFGLSR | NSHIAIAFDD | TKVKNRLTIE | LEVRTEAESG | 
    2850:
    LLFYMARINH | ADFATVQLRN | GLPYFSYDLG | SGDTHTMIPT | KINDGQWHKI | 
    2900:
    KIMRSKQEGI | LYVDGASNRT | ISPKKADILD | VVGMLYVGGL | PINYTTRRIG | 
    2950:
    PVTYSIDGCV | RNLHMAEAPA | DLEQPTSSFH | VGTCFANAQR | GTYFDGTGFA | 
    3000:
    KAVGGFKVGL | DLLVEFEFRT | TTTTGVLLGI | SSQKMDGMGI | EMIDEKLMFH | 
    3050:
    VDNGAGRFTA | VYDAGVPGHL | CDGQWHKVTA | NKIKHRIELT | VDGNQVEAQS | 
    3100:
    PNPASTSADT | NDPVFVGGFP | DDLKQFGLTT | SIPFRGCIRS | LKLTKGTGKP | 
    3122:
    LEVNFAKALE | LRGVQPVSCP | AN
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    String:
    SMR:
    MIM:
    KEGG:
    Pfam:
    UniGene:
    Uniprot:
     
    FOR
    ELISA Kit for Human Laminin subunit alpha-2
    Cat.:
    E9489h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Laminin subunit alpha-2
    Cat.:
    E9489m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Laminin subunit alpha-2
    Cat.:
    U9489m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Laminin subunit alpha-2
    Cat.:
    U9489h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Laminin subunit alpha-2
    Cat.:
    P9489Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Laminin subunit alpha-2
    Cat.:
    P9489Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Laminin subunit alpha-2
    Monoclonal Antibody for Human Laminin subunit alpha-2
    Protein for Human Laminin subunit alpha-2
    Protein for Human Laminin subunit alpha-2

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues."
      Vuolteenaho R. , Nissinen M. , Sainio K. , Byers M. , Eddy R. , Hirvonen H. , Shows T.B. , Sariola H. , Engvall E. , Tryggvason K.
      J. Cell Biol.124:381-394(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];VARIANT VAL-2587
      tissue: Placenta.
    2. 2.
      "Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy."
      Zhang X. , Vuolteenaho R. , Tryggvason K.
      J. Biol. Chem.271:27664-27669(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANT VAL-2587
    3. 3.
      "The DNA sequence and analysis of human chromosome 6."
      Mungall A.J. , Palmer S.A. , Sims S.K. , Edwards C.A. , Ashurst J.L. , Wilming L. , Jones M.C. , Horton R. , Hunt S.E. , Scott C.E. , Gilbert J.G.R. , Clamp M.E. , Bethel G. , Milne S. , Ainscough R. , Almeida J.P. , Ambrose K.D. , Andrews T.D. , more...
      Nature425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    4. 4.
      "Human laminin M chain: epitope analysis of its monoclonal antibodies by immunoscreening of cDNA clones and tissue expression."
      Hori H. , Kanamori T. , Mizuta T. , Yamaguchi N. , Liu Y. , Nagai Y.
      J. Biochem.116:1212-1219(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1360-3122
    5. 5.
      "Merosin, a tissue-specific basement membrane protein, is a laminin-like protein."
      Ehrig K. , Leivo I. , Argraves W.S. , Ruoslahti E. , Engvall E.
      Proc. Natl. Acad. Sci. U.S.A.87:3264-3268(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1981-3122;PARTIAL PROTEIN SEQUENCE;VARIANT VAL-2587
      tissue: Placenta.
    6. 6.
      "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
      Liu T. , Qian W.-J. , Gritsenko M.A. , Camp D.G. II , Monroe M.E. , Moore R.J. , Smith R.D.
      J. Proteome Res.4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-363
      tissue: Plasma.
    7. 7.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1901; ASN-1916; ASN-1920; ASN-2017 AND ASN-2648
      tissue: Liver.
    8. 8.
      "Novel single base polymorphisms and rare sequence variants in the laminin 2-chain coding region detected by RNA/SSCP analysis."
      Panicker S.G. , Mendell J.T. , Chen L. , Feng B. , Sahenk Z. , Marzluf G.A. , Amato A.A. , Mendell J.R.
      Hum. Mutat.13:174-174(1999)
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GLN-545; HIS-619; LEU-919; HIS-2586 AND LYS-2614
    9. 9.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    10. 10.
      "Congenital muscular dystrophy with primary partial laminin alpha-2 chain deficiency: molecular study."
      He Y. , Jones K.J. , Vignier N. , Morgan G. , Chevallay M. , Barois A. , Estournet-Mathiaud B. , Hori H. , Mizuta T. , Tome F.M.S. , North K.N. , Guicheney P.
      Neurology57:1319-1322(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MDC1A PRO-2564
    11. 11.
      "Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha-2 (LAMA2) deficiency."
      Tezak Z. , Prandini P. , Boscaro M. , Marin A. , Devaney J. , Marino M. , Fanin M. , Trevisan C.P. , Park J. , Tyson W. , Finkel R. , Garcia C. , Angelini C. , Hoffman E.P. , Pegoraro E.
      Hum. Mutat.21:103-111(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MDC1A TYR-527 AND ARG-862
    12. 12.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT [LARGE SCALE ANALYSIS] ALA-1160
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter